161 related articles for article (PubMed ID: 38825595)
1. Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs.
Kannan S; Gokul Krishna S; Gupta PK; Kolkundkar UK
Sci Rep; 2024 Jun; 14(1):12654. PubMed ID: 38825595
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a large source of primary mesenchymal stem cells tightly adhered to bone surfaces of human vertebral body marrow cavities.
Johnstone BH; Miller HM; Beck MR; Gu D; Thirumala S; LaFontaine M; Brandacher G; Woods EJ
Cytotherapy; 2020 Nov; 22(11):617-628. PubMed ID: 32873509
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow from periacetabular osteotomies as a novel source for human mesenchymal stromal cells.
Handke M; Rakow A; Singer D; Miebach L; Schulze F; Bekeschus S; Schoon J; Wassilew GI
Stem Cell Res Ther; 2023 Nov; 14(1):315. PubMed ID: 37924114
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells.
Mennan C; Garcia J; Roberts S; Hulme C; Wright K
Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254
[TBL] [Abstract][Full Text] [Related]
5. [Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].
Huang K; Zhou DH; Huang SL; Liang SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1049-53. PubMed ID: 16403278
[TBL] [Abstract][Full Text] [Related]
6. Effects of donor age, long-term passage culture, and cryopreservation on tonsil-derived mesenchymal stem cells.
Choi JS; Lee BJ; Park HY; Song JS; Shin SC; Lee JC; Wang SG; Jung JS
Cell Physiol Biochem; 2015; 36(1):85-99. PubMed ID: 25924984
[TBL] [Abstract][Full Text] [Related]
7. Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells.
Lo Surdo J; Bauer SR
Tissue Eng Part C Methods; 2012 Nov; 18(11):877-89. PubMed ID: 22563812
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
Front Immunol; 2020; 11():826. PubMed ID: 32435248
[No Abstract] [Full Text] [Related]
9. Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production.
Trivedi A; Miyazawa B; Gibb S; Valanoski K; Vivona L; Lin M; Potter D; Stone M; Norris PJ; Murphy J; Smith S; Schreiber M; Pati S
J Transl Med; 2019 Apr; 17(1):128. PubMed ID: 30995929
[TBL] [Abstract][Full Text] [Related]
10. Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation.
Mamidi MK; Nathan KG; Singh G; Thrichelvam ST; Mohd Yusof NA; Fakharuzi NA; Zakaria Z; Bhonde R; Das AK; Majumdar AS
J Cell Biochem; 2012 Oct; 113(10):3153-64. PubMed ID: 22615164
[TBL] [Abstract][Full Text] [Related]
11. Isolating Pediatric Mesenchymal Stem Cells with Enhanced Expansion and Differentiation Capabilities.
Knuth CA; Kiernan CH; Palomares Cabeza V; Lehmann J; Witte-Bouma J; Ten Berge D; Brama PA; Wolvius EB; Strabbing EM; Koudstaal MJ; Narcisi R; Farrell E
Tissue Eng Part C Methods; 2018 Jun; 24(6):313-321. PubMed ID: 29631483
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Pooled Wharton's Jelly Mesenchymal Stromal Cells (WJ-MSCs) and their Potential Role in Rheumatoid Arthritis Treatment.
Kannan S; Viswanathan P; Gupta PK; Kolkundkar UK
Stem Cell Rev Rep; 2022 Jun; 18(5):1851-1864. PubMed ID: 35113368
[TBL] [Abstract][Full Text] [Related]
14. Genomic and functional comparison of mesenchymal stromal cells prepared using two isolation methods.
Otsuru S; Hofmann TJ; Raman P; Olson TS; Guess AJ; Dominici M; Horwitz EM
Cytotherapy; 2015 Mar; 17(3):262-70. PubMed ID: 25659640
[TBL] [Abstract][Full Text] [Related]
15. Secretome studies of mesenchymal stromal cells (MSCs) isolated from three tissue sources reveal subtle differences in potency.
Konala VBR; Bhonde R; Pal R
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):689-700. PubMed ID: 33006709
[TBL] [Abstract][Full Text] [Related]
16. Modifiers of mesenchymal stem cell quantity and quality.
Russell AL; Lefavor R; Durand N; Glover L; Zubair AC
Transfusion; 2018 Jun; 58(6):1434-1440. PubMed ID: 29582436
[TBL] [Abstract][Full Text] [Related]
17. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.
Yaneselli K; Barrachina L; Remacha AR; Algorta A; Vitoria A; Cequier A; Romero A; Vázquez FJ; Maisonnave J; Rodellar C
Vet Immunol Immunopathol; 2019 Nov; 217():109944. PubMed ID: 31563725
[TBL] [Abstract][Full Text] [Related]
18. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
[TBL] [Abstract][Full Text] [Related]
19. Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture.
Kaplan A; Sackett K; Sumstad D; Kadidlo D; McKenna DH
Transfusion; 2017 Sep; 57(9):2216-2219. PubMed ID: 28653392
[TBL] [Abstract][Full Text] [Related]
20. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
